Navigation Links
Innovation and Medical Advances to be Highlighted on Final Day of Inaugural AdvaMed 2007 Conference
Date:10/3/2007

MedTech Conference Registration at 1,097

Keynote by George H.W. Bush Emphasizes Value of Medical Advances

WASHINGTON, Oct. 3 /PRNewswire-USNewswire/ -- AdvaMed 2007, the inaugural MedTech conference, will kick off its final day of programs with company presentations, panels focused on innovation and quality of life for patients, and a keynote address by former President George H.W. Bush, the 41st President of the United States.

Today, venture capitalists, investors, licensing officials, policy makers and others will hear more than 40 company presentations selected by the AdvaMed 2007 business development committee. Companies from 16 states and three countries, and at all stages of development, will present innovative technologies and intellectual property in the categories of Ophthalmology, Cardiovascular, Diagnostics, Imaging, Orthopedics, Wound Care and Additional Hot Topics. (Visit: http://www.advamed2007.com and click on the Business Development Forum page to see a complete overview of AdvaMed 2007 presenting companies.)

"The conference's theme today is 'Living Longer, Living Healthier,'" said Stephen J. Ubl, President and CEO of AdvaMed. "The presenting companies and keynote speaker today clearly showcase how innovations in medical technology such as hip, knee, and shoulder replacements, as well as advances in the diagnosis and treatment of cardiovascular disease, juvenile diabetes, and cancer allow individuals to live longer, healthier lives."

Former President George H.W. Bush, who had both hips replaced, will detail how medical advances have improved his life and the life of his family.

To view the full AdvaMed 2007 conference program visit http://www.AdvaMed2007.com

About AdvaMed:

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our members produce nearly 90 percent of the health care technology purchased annually in the United States and more than 50 percent purchased annually around the world. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit http://www.advamed.org.

About AdvaMed 2007:

AdvaMed 2007 is the premier medical technology conference and exhibition for business leaders, policymakers, investors, news media, patient advocates, and industry stakeholders from around the world. This year's conference offers a variety of workshops and panel discussions on subjects such as Medicare reimbursement, compliance, intellectual property, global market opportunities,

corporate finance, public policy, emerging company issues, 21st century health care and the value of medical technology.

Whether you need to finance, partner or license technology, AdvaMed 2007 introduces you to key decision-makers featuring a business development partnering program, company presentations, and an exhibition showcasing the latest medical technologies and products. Attendees have the opportunity to directly access key players, inform stakeholders as to the progress of our industry, and influence the business, political and financial climates so imperative to innovation.

For more information, visit http://www.AdvaMed2007.com or call 1-202-434- 7213.


'/>"/>
SOURCE AdvaMed; AdvaMed 2007
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Genetic innovation
2. Biocon To Shift Focus On Innovation To Accelerate Growth
3. IIT Delhi To Display Its Technological Innovations In Open House
4. Patent for Seminal RNAi innovation Cleared in Australia
5. Innovation Needed In The Field Of Diagnostics: Nair
6. A young scientist recognized for biomechanics innovations
7. Blood Safety, Supply, and Innovations Addressed at Conference
8. New Innovation in Clubfoot Treatment
9. Check if your “Favourite medical web-site” is indulging in Quackey
10. Teens turning to Internet for medical queries
11. Robots craft medical history
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
(Date:6/24/2016)... Frederick, Maryland (PRWEB) , ... June 24, 2016 ... ... Mid-Atlantic Angels is actively feeding the Frederick area economy by obtaining investment capital ... support over the past 2½ years that have already resulted in more than ...
(Date:6/24/2016)... ... 2016 , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The ... members that have been wounded in battle and their families. Venture Construction Group is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Advanced Plastic Surgery ... Arizona pageant as its official Medspa Sponsor. Dr. Josh Olson, a board-certified plastic ... , Dr. Olson says the decision to support the pageant in an ...
(Date:6/24/2016)... ... June 24, 2016 , ... To succeed under value-based ... however, are unsure how to move forward, given the need to sustain current ... forward tailored to an organization’s specific needs. , PYA Principal Martie Ross states, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: